North America Leukapheresis Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Leukapheresis Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Leukapheresis Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Leukapheresis Market Regional Analysis

6.2 North America Leukapheresis Market Revenue 2019-2028 (US$ Million)

6.3 North America Leukapheresis Market Forecast Analysis

7. North America Leukapheresis Market Analysis – by Product Type

7.1 Leukapheresis Devices

7.1.1 Overview
7.1.2 Leukapheresis Devices: North America Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Leukapheresis Disposables

7.2.1 Overview
7.2.2 Leukapheresis Disposables: North America Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Leukapheresis Market Analysis – by Application

8.1 Research Applications

8.1.1 Overview
8.1.2 Research Applications: North America Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Therapeutic Applications

8.2.1 Overview
8.2.2 Therapeutic Applications: North America Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Leukapheresis Market Analysis – by End User

9.1 Blood Component Providers and Blood Centers

9.1.1 Overview
9.1.2 Blood Component Providers and Blood Centers: North America Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Academic and Research Institutes

9.2.1 Overview
9.2.2 Academic and Research Institutes: North America Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies: North America Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Hospitals and Transfusion Centers

9.4.1 Overview
9.4.2 Hospitals and Transfusion Centers : North America Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Leukapheresis Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Leukapheresis Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Leukapheresis Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Leukapheresis Market Breakdown, by Product Type
10.2.1.1.2 US: North America Leukapheresis Market Breakdown, by Application
10.2.1.1.3 US: North America Leukapheresis Market Breakdown, by End User

10.2.1.2 Canada: North America Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Leukapheresis Market Breakdown, by Product Type
10.2.1.2.2 Canada: North America Leukapheresis Market Breakdown, by Application
10.2.1.2.3 Canada: North America Leukapheresis Market Breakdown, by End User

10.2.1.3 Mexico : North America Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Leukapheresis Market Breakdown, by Product Type
10.2.1.3.2 Mexico : North America Leukapheresis Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Leukapheresis Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Asahi Kasei Corporation

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Fresenius SE & Co. KGaA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Haemonetics Corporation

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Terumo Corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 STEMCELL Technologies Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 HemaCare

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Macopharma

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 AllCells

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 STEMEXPRESS

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 BioIVT

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Leukapheresis Market